Swedish Pharmaceuticals & Biotech Financially Fit Penny Stocks

Elicera Therapeutics

Market Cap: SEK 81.8m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 42.6m

Develops drugs for lipid related diseases in Sweden.

Newbury Pharmaceuticals

Market Cap: SEK 83.4m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Biovica International

Market Cap: SEK 96.5m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

Ascelia Pharma

Market Cap: SEK 278.7m

A biotech company, focuses on orphan oncology treatments in Sweden.

AcouSort

Market Cap: SEK 59.4m

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.

NextCell Pharma

Market Cap: SEK 222.2m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

AlzeCure Pharma

Market Cap: SEK 201.3m

A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Modus Therapeutics Holding

Market Cap: SEK 44.9m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

AroCell

Market Cap: SEK 124.4m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Intervacc

Market Cap: SEK 339.1m

Develops novel veterinary vaccines for animals in Sweden.

Annexin Pharmaceuticals

Market Cap: SEK 175.3m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Attana

Market Cap: SEK 9.7m

Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

Nanologica

Market Cap: SEK 134.3m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.

Kancera

Market Cap: SEK 145.4m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

Stayble Therapeutics

Market Cap: SEK 29.2m

Develops injectable treatment for chronic pain triggered by disc degeneration.

Alzinova

Market Cap: SEK 230.0m

A biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Toleranzia

Market Cap: SEK 120.0m

A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.

Genetic Analysis

Market Cap: NOK 36.0m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Egetis Therapeutics

Market Cap: SEK 1.3b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Medivir

Market Cap: SEK 155.9m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Aptahem

Market Cap: SEK 8.6m

A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

Spago Nanomedical

Market Cap: SEK 80.1m

A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.

Level Bio

Market Cap: SEK 22.8m

Designs, develops, and distributes diagnostics products in the Nordic region and internationally.

Dicot Pharma

Market Cap: SEK 546.1m

Engages in the development of pharmaceutical products in Sweden.

Vivesto

Market Cap: SEK 129.1m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

WntResearch

Market Cap: SEK 5.4m

A biotech company, develops therapies to prevent the metastatic process.

Sprint Bioscience

Market Cap: SEK 46.6m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Enzymatica

Market Cap: SEK 1.1b

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.

PExA

Market Cap: SEK 10.7m

Develops and commercializes diagnostic products in various respiratory diseases, such as asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases.

CombiGene

Market Cap: SEK 47.9m

Engages in the development of gene therapy for severe life-altering diseases in Sweden.

Isofol Medical

Market Cap: SEK 319.8m

A clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally.

LIDDS

Market Cap: SEK 14.4m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

Hamlet BioPharma

Market Cap: SEK 705.4m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Pila Pharma

Market Cap: SEK 82.7m

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden.